Sigma Healthcare Ltd

ASX:SIG (Australia)  
A$ 1.31 (+0.38%) Jun 21
261.00
P/B:
2.44
Market Cap:
A$ 2.13B ($ 1.42B)
Enterprise V:
A$ 1.91B ($ 1.28B)
Volume:
17.56M
Avg Vol (2M):
9.04M
Trade In:
Volume:
17.56M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sigma Healthcare Ltd ( ) from 2017 to Jun 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sigma Healthcare stock (ASX:SIG) PE ratio as of Jun 22 2024 is 261. More Details

Sigma Healthcare Ltd (ASX:SIG) PE Ratio (TTM) Chart

To

Sigma Healthcare Ltd (ASX:SIG) PE Ratio (TTM) Historical Data

Total 1279
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Sigma Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-22 261.0 2024-04-22 260.0
2024-06-21 261.0 2024-04-19 251.0
2024-06-20 260.0 2024-04-18 255.0
2024-06-19 260.0 2024-04-17 258.0
2024-06-18 253.0 2024-04-16 251.0
2024-06-17 242.0 2024-04-15 254.0
2024-06-14 232.0 2024-04-12 255.0
2024-06-13 232.0 2024-04-11 254.0
2024-06-12 241.0 2024-04-10 260.0
2024-06-11 236.0 2024-04-09 251.0
2024-06-10 235.0 2024-04-08 244.0
2024-06-07 235.0 2024-04-05 236.0
2024-06-06 236.0 2024-04-04 241.0
2024-06-05 241.0 2024-04-03 245.0
2024-06-04 240.0 2024-04-02 262.0
2024-06-03 242.0 2024-04-01 259.0
2024-05-31 251.0 2024-03-29 259.0
2024-05-30 248.0 2024-03-28 259.0
2024-05-29 247.0 2024-03-27 259.0
2024-05-28 249.0 2024-03-26 250.0
2024-05-27 247.0 2024-03-25 246.0
2024-05-24 244.0 2024-03-22 240.0
2024-05-23 244.0 2024-03-21 246.0
2024-05-22 250.0 2024-03-20 243.0
2024-05-21 249.0 2024-03-19 250.0
2024-05-20 248.0 2024-03-18 246.0
2024-05-17 247.0 2024-03-15 245.0
2024-05-16 252.0 2024-03-14 243.0
2024-05-15 250.0 2024-03-13 248.0
2024-05-14 248.0 2024-03-12 249.0
2024-05-13 250.0 2024-03-11 241.0
2024-05-10 254.0 2024-03-08 243.0
2024-05-09 257.0 2024-03-07 237.0
2024-05-08 259.0 2024-03-06 230.0
2024-05-07 257.0 2024-03-05 229.0
2024-05-06 258.0 2024-03-04 229.0
2024-05-03 259.0 2024-03-01 225.0
2024-05-02 251.0 2024-02-29 229.0
2024-05-01 251.0 2024-02-28 224.0
2024-04-30 253.0 2024-02-27 223.0
2024-04-29 260.0 2024-02-26 224.0
2024-04-26 253.0 2024-02-23 222.0
2024-04-25 259.0 2024-02-22 219.0
2024-04-24 259.0 2024-02-21 215.0
2024-04-23 262.0 2024-02-20 218.0

Sigma Healthcare Ltd (ASX:SIG) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.